Search Results - Levin, Mark-David

  • Showing 1 - 2 results of 2
Refine Results
  1. 1

    Daratumumab or active monitoring for high-risk smoldering multiple myeloma by Dimopoulos, Meletios A. (Author) , Voorhees, Peter M. (Author) , Schjesvold, Fredrik (Author) , Cohen, Yael C. (Author) , Hungria, Vania (Author) , Sandhu, Irwindeep (Author) , Lindsay, Jindriska (Author) , Baker, Ross I. (Author) , Suzuki, Kenshi (Author) , Kosugi, Hiroshi (Author) , Levin, Mark-David (Author) , Beksac, Meral (Author) , Stockerl-Goldstein, Keith (Author) , Oriol, Albert (Author) , Mikala, Gabor (Author) , Garate, Gonzalo (Author) , Theunissen, Koen (Author) , Spicka, Ivan (Author) , Mylin, Anne K. (Author) , Bringhen, Sara (Author) , Uttervall, Katarina (Author) , Pula, Bartosz (Author) , Medvedova, Eva (Author) , Cowan, Andrew J. (Author) , Moreau, Philippe (Author) , Mateos, Maria-Victoria (Author) , Goldschmidt, Hartmut (Author) , Ahmadi, Tahamtan (Author) , Sha, Linlin (Author) , Cortoos, Annelore (Author) , Katz, Eva G. (Author) , Rousseau, Els (Author) , Li, Liang (Author) , Dennis, Robyn M. (Author) , Carson, Robin (Author) , Rajkumar, S. Vincent (Author) ,


    Get full text
    Article (Journal) Online Resource
  2. 2

    Daratumumab for patients with myeloma with early or late relapse after initial therapy: subgroup analysis of CASTOR and POLLUX by Spencer, Andrew (Author) , Moreau, Philippe (Author) , Mateos, Maria-Victoria (Author) , Goldschmidt, Hartmut (Author) , Suzuki, Kenshi (Author) , Levin, Mark-David (Author) , Sonneveld, Pieter (Author) , Orlowski, Robert Z. (Author) , Yoon, Sung-Soo (Author) , Usmani, Saad Z. (Author) , Weisel, Katja (Author) , Reece, Donna (Author) , Ahmadi, Tahamtan (Author) , Pei, Huiling (Author) , Mayo, Wendy Garvin (Author) , Gai, Xue (Author) , Carey, Jodi (Author) , Bartlett, J. Blake (Author) , Carson, Robin (Author) , Dimopoulos, Meletios A. (Author) ,


    Get full text
    Article (Journal) Online Resource